Home › Stocks › CGEM

Cullinan Therapeutics, Inc. (CGEM): insider buying, hedge funds & Congress trades

Cullinan Therapeutics, Inc. (CGEM): 3 insider purchases in the last two years.

Insider buying

FiledInsiderSharesPriceValueType
Oct 30, 2025Nichols Weston
TenPercentOwner
165,667$8.40$1.4Mno history
Oct 21, 2025Lynx1 Capital Management LP
TenPercentOwner
248,749$8.46$2.1Mno history
Oct 10, 2025Lynx1 Capital Management LP
TenPercentOwner
1,459,641$6.73$9.8Mno history

Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.

Get alerts for CGEM

Free account. Know when insiders, famous funds or Congress trade it.

Start free